Literature DB >> 16581211

Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.

C A Ventura1, S Tommasini, A Falcone, I Giannone, D Paolino, V Sdrafkakis, M R Mondello, G Puglisi.   

Abstract

We evaluated the ability of two modified cyclodextrins, hydroxypropyl-beta-cyclodextrin (HP-beta-Cyd) and 2,6-di-O-methyl-beta-cyclodextrin (DM-beta-Cyd), to influence the percutaneous absorption through isolated human stratum corneum and epidermis (SCE) of celecoxib (CCB). Previous studies demonstrated that DM-beta-Cyd includes the drug, producing a significant increase of water solubility (0.5 mg/ml at 25 degrees C) and dissolution rate of CCB. In this work chemical-physical characterization studies were performed to evaluate the ability of HP-beta-Cyd to include CCB. We showed that only an external interaction could exist between CCB and HP-beta-Cyd that positively influences the water solubility of the drug (0.12 mg/ml at 25 degrees C for CCB-HP-beta-CyD system and 4.12 x 10(-3) mg/ml at 25 degrees C for free CCB). In vitro percutaneous experiments were performed using samples in solution and in suspension containing different Cyd concentrations. Both HP-beta-Cyd and DM-beta-Cyd enhanced drug flux through SCE by means of an increase of dissolution rate of the drug as well as a direct action on the stratum corneum (SC). Histological analysis of treated SCE showed a protective effect of the two Cyds towards an invasive action shown by CCB on SC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581211     DOI: 10.1016/j.ijpharm.2006.02.006

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer.

Authors:  Yara Peluso Cid; Vinícius Pedrazzi; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

2.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

3.  Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.

Authors:  Angela Lopedota; Annalisa Cutrignelli; Valentino Laquintana; Nunzio Denora; Rosa Maria Iacobazzi; Mara Perrone; Elisabetta Fanizza; Maria Mastrodonato; Donatella Mentino; Antonio Lopalco; Nicoletta Depalo; Massimo Franco
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

4.  Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation.

Authors:  M S Nagarsenker; L Amin; Abhijit A Date
Journal:  AAPS PharmSciTech       Date:  2008-11-19       Impact factor: 3.246

5.  Topical Nano-Vesicular Spanlastics of Celecoxib: Enhanced Anti-Inflammatory Effect and Down-Regulation of TNF-α, NF-кB and COX-2 in Complete Freund's Adjuvant-Induced Arthritis Model in Rats.

Authors:  Eman Alaaeldin; Heba A Abou-Taleb; Soad A Mohamad; Mahmoud Elrehany; Shereen S Gaber; Heba F Mansour
Journal:  Int J Nanomedicine       Date:  2021-01-08

6.  Dasatinib/HP-β-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders.

Authors:  Annalisa Cutrignelli; Francesca Sanarica; Antonio Lopalco; Angela Lopedota; Valentino Laquintana; Massimo Franco; Brigida Boccanegra; Paola Mantuano; Annamaria De Luca; Nunzio Denora
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.